Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2 3167,"Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5.",blood glucose amount,,RS:0004409,Jcl:WI,male,154 days,7,,CMO:0000042,plasma glucose level,,,,59.04,mg/dl,2.16,5.7148,MMO:0000315,plasma glucose analysis,,0.0,,,,,fasting,110209,fasting, 3167,"Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5.",blood glucose amount,,RS:0004409,Jcl:WI,male,154 days,7,,CMO:0000042,plasma glucose level,,,,68.22,mg/dl,3.6,9.5247,MMO:0000315,plasma glucose analysis,,0.0,,,,,vildagliptin (30 mg/kg/d) (for 106 days) then fasting,110210,vildagliptin (30 mg/kg/d) (for 106 days),fasting